Navifus Corporation

This early-stage study tests a device that uses sound waves to help a standard cancer drug reach the brain more effectively in people with recurrent glioblastoma, an aggressive brain tumor. Ten participants will receive the drug bevacizumab along with focused ultrasound to see if…

This study is testing if using a focused ultrasound device (NaviFUS System) along with a standard cancer drug (Avastin) works better than the drug alone for adults with recurrent glioblastoma, a very aggressive brain tumor. The ultrasound is meant to help the drug reach the tumor…

This study tests a device called NaviFUS™ that uses low-intensity focused ultrasound to calm overactive brain areas in people with epilepsy that doesn't respond to medication. About 16 adults will be randomly assigned to receive the ultrasound treatment or continue standard care.…

This early study tests if low-intensity focused ultrasound can safely reduce seizures in people with temporal lobe epilepsy that doesn't respond to medication. Eight adults will receive the non-invasive treatment. The main goal is to check safety and see if seizure frequency impr…